ID26873A - Kombinasi terapeutik yang terdiri dari modulator reseptor estrogen selektif dan hormon paratiroid - Google Patents

Kombinasi terapeutik yang terdiri dari modulator reseptor estrogen selektif dan hormon paratiroid

Info

Publication number
ID26873A
ID26873A IDW20002626A ID20002626A ID26873A ID 26873 A ID26873 A ID 26873A ID W20002626 A IDW20002626 A ID W20002626A ID 20002626 A ID20002626 A ID 20002626A ID 26873 A ID26873 A ID 26873A
Authority
ID
Indonesia
Prior art keywords
paratiroid
hormones
estrogen receptor
receptor modulators
selective estrogen
Prior art date
Application number
IDW20002626A
Other languages
English (en)
Indonesian (id)
Inventor
Hua Zhu Ke
David Duane Thomson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID26873A publication Critical patent/ID26873A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
IDW20002626A 1998-06-16 1999-05-26 Kombinasi terapeutik yang terdiri dari modulator reseptor estrogen selektif dan hormon paratiroid ID26873A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8947998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
ID26873A true ID26873A (id) 2001-02-15

Family

ID=22217879

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002626A ID26873A (id) 1998-06-16 1999-05-26 Kombinasi terapeutik yang terdiri dari modulator reseptor estrogen selektif dan hormon paratiroid

Country Status (34)

Country Link
US (1) US6132774A (is)
EP (1) EP1094808A1 (is)
JP (1) JP2002518323A (is)
KR (1) KR20010052818A (is)
CN (1) CN1305373A (is)
AP (1) AP9901580A0 (is)
AR (1) AR018867A1 (is)
AU (1) AU3725999A (is)
BG (1) BG105125A (is)
BR (1) BR9911228A (is)
CA (1) CA2335078A1 (is)
CO (1) CO5070584A1 (is)
EA (1) EA200001199A1 (is)
GT (1) GT199900066A (is)
HN (1) HN1999000063A (is)
HR (1) HRP20000858A2 (is)
HU (1) HUP0102759A3 (is)
ID (1) ID26873A (is)
IL (1) IL139588A0 (is)
IS (1) IS5719A (is)
MA (1) MA26649A1 (is)
NO (1) NO20006313D0 (is)
NZ (1) NZ508039A (is)
OA (1) OA11566A (is)
PA (1) PA8471201A1 (is)
PE (1) PE20000644A1 (is)
PL (1) PL344982A1 (is)
SK (1) SK18922000A3 (is)
TN (1) TNSN99119A1 (is)
TR (1) TR200003567T2 (is)
UA (1) UA60367C2 (is)
WO (1) WO1999065482A1 (is)
YU (1) YU75800A (is)
ZA (1) ZA993972B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
ES2328384T3 (es) * 2004-11-23 2009-11-12 Warner-Lambert Company Llc Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
US7790745B2 (en) 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
TW201043595A (en) * 2009-03-13 2010-12-16 Organon Nv Tetrahydronaphthalen-2-ol derivatives
DE102010027016A1 (de) 2010-07-09 2012-01-12 Universitätsklinikum Jena Steroid-Styrylfarbstoff-Konjugate zur Simulation und direkten lichtoptischen Detektion des Verhaltens von Steroiden im lebenden biologischen Gewebe und in Gegenwart von steroidbindenden Proteinen
CN111067907A (zh) * 2018-10-18 2020-04-28 常州大学 孕激素在抑制血管内皮生长因子表达中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254595A (en) * 1988-12-23 1993-10-19 Elf Sanofi Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
NZ508039A (en) 2003-03-28
AR018867A1 (es) 2001-12-12
IS5719A (is) 2000-11-21
CO5070584A1 (es) 2001-08-28
IL139588A0 (en) 2002-02-10
PA8471201A1 (es) 2000-09-29
CN1305373A (zh) 2001-07-25
BG105125A (en) 2001-11-30
OA11566A (en) 2004-05-26
EA200001199A1 (ru) 2001-04-23
PE20000644A1 (es) 2000-08-02
PL344982A1 (en) 2001-11-19
HRP20000858A2 (en) 2001-10-31
UA60367C2 (uk) 2003-10-15
WO1999065482A1 (en) 1999-12-23
US6132774A (en) 2000-10-17
CA2335078A1 (en) 1999-12-23
BR9911228A (pt) 2001-02-13
GT199900066A (es) 2000-10-31
ZA993972B (en) 2000-12-15
AU3725999A (en) 2000-01-05
SK18922000A3 (sk) 2001-09-11
KR20010052818A (ko) 2001-06-25
YU75800A (sh) 2003-12-31
JP2002518323A (ja) 2002-06-25
TR200003567T2 (tr) 2001-06-21
TNSN99119A1 (fr) 2005-11-10
HUP0102759A2 (hu) 2002-03-28
NO20006313L (no) 2000-12-12
HN1999000063A (es) 2000-01-12
AP9901580A0 (en) 1999-06-30
HUP0102759A3 (en) 2002-12-28
NO20006313D0 (no) 2000-12-12
EP1094808A1 (en) 2001-05-02
MA26649A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
ID27986A (id) Pengobatan terhadap gangguan sistem syaraf pusat dengan modulator reseptor estrogen selektif
IL204486A0 (en) Selective androgen receptor modulators and methods of uses thereof
NO20025143D0 (no) Modulatorer av reseptorer for paratyroid hormon og paratyriod hormonforbundet protein
NO20015272L (no) Glukokortikoid reseptor modulatorer
DE69712642D1 (de) Transdermale anwendung von natürlich auftretenden steroid hormonen
DE69927084D1 (de) Sigma-delta Modulator und Modulationsverfahren
PL354410A1 (en) Bicyclic androgen and progesterone receptor modulator compounds and methods
DE69822449D1 (de) Neue cannabinoidrezeptor-modulatoren
HUP0204029A3 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
NO963049D0 (no) Modulatorer av forankrende proteinfunksjon
ID23673A (id) Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
IS5719A (is) Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni
ID24358A (id) Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogen
IL120485A0 (en) Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
ID23653A (id) Pencegahan kanker payudara dengan modulator reseptor estrogen selektif
NO20006381D0 (no) Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
ID27599A (id) Gabungan-gabungan yang mengandung nilai pengobatan dari modulator-modulator reseptor estrogen (selektif) (serm) dan sekretagogue-sekretagogue hormon pertumbuhan (ghs) untuk pengobatan kelemahan kerangka otot
NO975851D0 (no) Cytoplasmatiske modulatorer av integrinregulering/-signalisering
IL120759A0 (en) Modulators of the function of fas receptors and other proteins
ID22345A (id) Penghilangan 6-aminokapronitril dari campuran-campuran yang terdiri dari 6-aminokapronitril dan suatu imina
DE59802084D1 (de) Neue lipopolyamine, deren darstellung und anwendung
ID22685A (id) Penghilangan 6-aminokapronitril dari campuran yang terdiri dari 6-aminokapronitril dan imina
ID30106A (id) Pelarutan enzimatik modulator-modulator reseptor estrogen selektif
IL123758A0 (en) Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
IL138383A0 (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins